tradingkey.logo

Microchip Technology Q3 adjusted EPS beats expectations

ReutersFeb 5, 2026 9:27 PM


Overview

  • Embedded control solutions provider's fiscal Q3 revenue up 15.6% yr/yr

  • Adjusted EPS for fiscal Q3 beat analyst expectations

  • Company declared quarterly dividend of 45.5 cents per share for March quarter


Outlook

  • Microchip expects Q4 fiscal 2026 net sales between $1.240 bln and $1.280 bln

  • Company anticipates gross margins to expand towards long-term target of 65%

  • Microchip plans capital expenditures between $20 mln and $23 mln for qtr ending March 31


Result Drivers

  • MARGIN EXPANSION - Significant margin expansion attributed to operational improvements and inventory reduction

  • CONNECTIVITY BUSINESS - Strong momentum in connectivity business driven by modernization cycles in automotive and industrial markets

  • INVENTORY REDUCTION - Substantial progress on inventory reduction positioning for improved operational efficiency


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Adjusted EPS

Beat

$0.44

$0.41 (22 Analysts)

Q3 EPS

$0.06

Q3 Adjusted Net Income

$252.80 mln

Q3 Net Income

$34.90 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 21 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the semiconductors peer group is "buy"

  • Wall Street's median 12-month price target for Microchip Technology Inc is $85.00, about 8.7% above its February 4 closing price of $78.23

  • The stock recently traded at 32 times the next 12-month earnings vs. a P/E of 30 three months ago

Press Release: ID:nGNX17WrF

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI